Member Info for ScienceNorth

Which of the products actually sold……was it across range? I’m guessing it wasn’t.

I feel betrayed by the claims of it selling well and aspirations of clearing stock, when they knew nothing was selling. They lack respect for us all and even themselves.

It should now be rebranded ‘skin minus sells’!

The big claims of the marketing strategy….which confirmed my previous comments about targeting the wrong demographic. The lack of explanation for the marinaud deal collapse. Reluctance to explain the benefits in terms the public understand. The complete disregard for company origins and underhand change from a cancer drug research company to a cosmetic retailer. Weaker reputation than Del Boy in the markets!

I have a small (misguided) hope they self reflect and pull something out of the bag…..but only on the basis that they have so much of their own tied up in the company.

The company previously had licensing deals in place for the oncology drugs they were founded with but we don’t hear of anything from them….financially or otherwise. They also said they had lots of IP but is this still being covered? It’s important to reassure me that S+C isn’t the end and the out…

An important investment factor for me was the oncology aspect…

The quicker the company can get back to its foundations in treatment and prevention of cancer the better from my view. The clue is in company name.

I’m not excited at the minute with the current status and direction….fearful that we will get bogged down in quicksand of cosmetics.

All mention of the backbone of company in oncology has slipped from website.

The company is bigger than S+C, which is subsidiary that should be made clear, as it’s affecting investments.

Is that a panic or a planned strategy I’m not sure….

Looks like the excitement is not coming through….SP rock bottom.

Is the marketing strategy not working or do we just sit tight and hope we are wrong and there is a huge sales announcement soon?

It’s the fact that all pipelines have been removed from everywhere that worries me.

When company started it was all about new novel cancer drugs…..then it was SOL….and now it’s cosmetics.

What is its goal?

What is happening with full portfolio of company?

When I invested they were talking about Sol and cancer treatments, with lots of excitement about pipeline.

This has all now disappeared from website and the pipeline has gone.

It seems like they are just a skincare company now….does anyone else get that impression?

That would be disappointing as the potential for the benefits of this company looked massive….beyond just a quick buck.

I agree….

I think the youthful market is not where this should be targeted. Due to cost and it’s selling points.

Similar with the science…..the message is not getting across and how this is better. Most people won’t know what mitochondria is….so will not appreciate this.

I think more work is needed to communicate the science benefits to the lay person. Saying things like this product penetrates far deeper into the skin than any comparator and actually gets to the places where the damage occurs, so combines luxury of a skin cream with the distinct benefits of science backed action to repair skin damage. A first in the marketplace.

I agree the oncology focus of the company has been lost entirely….with no mention of the exciting pipeline of Sol or even the cancer drugs they developed.

I feel that once the skincare angle is sold/failed then that’ll be end.

Hope I’m wrong..

Not exactly the type of influencer I was expecting….a young perfect skinned cosplayer. I thought the target market was the older person who had some skin damage to repair and who could afford this range.

These demographics are miles apart

I feel a marketing flop……with the initial big hit missed severely.

Wow….Not exactly cheap. Hopefully the message of science gets through to customers.

Can see why this wasn’t going to work in Superdrug….

At that price I think we’d only see it Harrods……

And company is located in Switzerland for this purpose?🇨🇭😀

At the minute it’s all just words….so let’s see how they handle this and get customers on board.

I still have a niggle about marionauds withdrawal, if they truly believed this a blockbuster product. What was it that gave them cold feet, as patent was resolved without repercussions (or was it?)

Markets haven’t yet responded favourably either

I think that’s very hopeful…

I think someone young would not be the target…it’s aimed at the more mature client to firm up skin and halt damage.

However, at this rate I think the board would be lucky to get a second or third rate influencer. The closest to a beautician they’d end up with is Sweeney Todd….

It does look like they’re cutting it fine with all this.

Are we clear what territories they are going for, as that will have implications for language, influencer, platform and ultimately cost.

With weeks/days to go till launch…..still no excitement on the market. Why is it all so quiet?

The products are due to hit the markets in Q3 2025…….ie within weeks. There is new science backing it up and stable IP position.

But still no excitement on the markets and ever decreasing price.

What’s happening?

If the deal is as good as they indicate why is this not reflected in the price?

Plummeting rather than shooting up.

Is this one promise too many?